Eli Lilly

Highest-Yielding Pharma Stocks (You Might Actually Want to Buy)
Motley Fool
Tue, 01/4/11 - 09:35 am
Eli Lilly
Bristol-Myers Squibb
Abbott Laboratories
Perrigo Company
JNJ
Medicis
The Most Promising Dividends in Pharmaceuticals
Motley Fool
Wed, 12/29/10 - 11:48 am
dividends
Eli Lilly
GSK
Bristol-Myers Squibb
Pfizer
Merck
Abbott Laboratories
JNJ
Merdian
Sanofi
Novartis
AstraZeneca
Teva Pharmaceuticals
Novo Nordisk
The Top Dividend Aristocrats in Pharma and Biotech
Motley Fool
Wed, 12/29/10 - 10:41 am
dividends
JNJ
Abbott Laboratories
Eli Lilly
Another Disappointment for Eli Lilly: Worries Freeze Melanoma Trial
Seeking Alpha
Sun, 12/19/10 - 12:16 pm
Eli Lilly
melanoma
tasisulam
Report on fraud a bitter pill for Pfizer, GlaxoSmithKline
The Day, CT
Sat, 12/18/10 - 12:52 pm
Pfizer
GSK
Eli Lilly
Schering Plough
Lilly Suspends Late-Stage Trial for Melanoma Drug in Which 12 People Died
Bloomberg
Tue, 12/14/10 - 11:27 am
melanoma
Eli Lilly
clinical trials
tasisulam
Clinical Data: Highly Anticipated FDA Decision Could Revive Interest
Seeking Alpha
Tue, 12/14/10 - 11:04 am
FDA
major depressive disorder
Forest Labs
GSK
Eli Lilly
Merck
Clinical Data
Vilazodone
Pfizer
Eli Lilly suspends skin cancer study over safety concerns
Yahoo/AP
Mon, 12/13/10 - 08:33 pm
Eli Lilly
skin cancer
tasisulam
Big Pharma's Lost Stock Market Decade
Seeking Alpha
Mon, 12/13/10 - 08:32 pm
Big Pharma
Abbott Laboratories
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
Is Eli Lilly's Stock Cheap by the Numbers?
Motley Fool
Mon, 12/13/10 - 10:05 am
Eli Lilly
A Tale of Two Pharmas: Outlooks for Lilly and Merck
Seeking Alpha
Thu, 12/9/10 - 12:10 pm
Eli Lilly
Merck
Can New Leadership Rejuvenate Big Pharma?
Investopedia
Wed, 12/8/10 - 12:25 pm
AstraZeneca
GSK
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Is a Revenue Miss Coming for Eli Lilly?
Motley Fool
Tue, 11/30/10 - 10:54 am
Eli Lilly
RNAi Is On Sale
Motley Fool
Tue, 11/30/10 - 10:52 am
RNAi
Merck
Alnylam
Pfizer
Amgen
Novartis
Eli Lilly
Roche
Pfizer, Incyte and Eli Lilly drug developments could transform future of rheumatoid arthritis therapy
FT.com
Mon, 11/29/10 - 12:44 pm
rheumatoid arthritis
Pfizer
Incyte
Eli Lilly
Rigel
JAK inhibitors
fostamatinib
Let’s Have a Healthy Dialogue in the Drug Sector
WSJ Online
Mon, 11/29/10 - 09:07 am
Bayer
GSK
Novartis
Eli Lilly
JNJ
social media
AstraZeneca
twitter
Lilly, Acrux get FDA OK for topical testosterone
Marketwatch
Wed, 11/24/10 - 07:58 am
Acrux
Eli Lilly
FDA
testosterone
Axiron
Top 15 Pharma R&D Budgets
Fierce Pharma
Thu, 11/18/10 - 08:47 am
R&D
Roche
Pfizer
Novartis
JNJ
Sanofi
GSK
Merck
Takeda
AstraZeneca
Eli Lilly
Boehringer Ingelheim
Bristol-Myers Squibb
Abbott Laboratories
Daiichi Sankyo
Astellas
Lilly Ventures leads $24M round for Cerulean's PhII
Fierce Biotech
Mon, 11/15/10 - 10:51 am
Eli Lilly
financing
Cerulean
Series C
lung cancer
Moody’s Downgrade Adds to Eli Lilly's Growing Burden
Seeking Alpha
Sun, 11/14/10 - 01:30 pm
Eli Lilly

Pages